B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OPN1LW

MOLECULAR TARGET

opsin 1, long wave sensitive

UniProt: P04000NCBI Gene: 59561 compounds

OPN1LW (opsin 1, long wave sensitive) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OPN1LW

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Retinaldehyde0.691

About OPN1LW as a Drug Target

OPN1LW (opsin 1, long wave sensitive) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented OPN1LW interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OPN1LW inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.